Zydus receives final approval from the USFDA for zinc sulfate injection pharmacy bulk package vials
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)
Tadalafil Tablets USP, 20 mg had annual sales of USD 61 mn in the United States (IQVIA MAT April 2023)
Subscribe To Our Newsletter & Stay Updated